Cingulate Total Liab vs Short Term Debt Analysis

CING Stock

USD 4.70 0.02 0.42%

Cingulate financial indicator trend analysis is way more than just evaluating Cingulate prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cingulate is a good investment. Please check the relationship between Cingulate Total Liab and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

Total Liab vs Short Term Debt

Total Liab vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cingulate Total Liab account and Short Term Debt. At this time, the significance of the direction appears to have strong relationship.

The correlation between Cingulate's Total Liab and Short Term Debt is 0.77. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Cingulate, assuming nothing else is changed. The correlation between historical values of Cingulate's Total Liab and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Cingulate are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Total Liab i.e., Cingulate's Total Liab and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.77

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Short Term Debt

Most indicators from Cingulate's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cingulate current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.The current Selling General Administrative is estimated to decrease to about 7.1 M. The current Issuance Of Capital Stock is estimated to decrease to about 5.3 M

	2021	2022	2023	2024 (projected)
Total Operating Expenses	20.7M	17.5M	22.8M	17.5M
Cost Of Revenue	808.4K	622.0K	582.9K	667.6K

Total Operating Expenses Cost Of Revenue

Cingulate fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock
Total Assets		-0.14	0.12	-0.27	0.03	0.4	0.09	-0.05	-0.97	-0.56	0.99	0.01	0.11	0.99	0.99	-0.7	-0.4	-0.21	-0.36	0.76	0.46	-0.43	0.77	0.33	0.99	-0.4
Short Long Term Debt Total	-0.14		0.34	0.73	-0.97	0.56	-0.56	0.09	0.37	0.2	-0.15	-0.56	-0.54	-0.15	-0.28	-0.27	-0.43	-0.53	-0.54	0.53	0.47	0.72	0.1	0.43	-0.08	-0.43
Other Current Liab	0.12	0.34		0.73	-0.21	0.84	-0.83	0.71	-0.11	0.45	0.21	-0.87	-0.78	0.21	0.06	-0.56	-0.91	-0.89	-0.83	0.3	0.87	0.61	0.62	0.91	0.21	-0.38
Total Current Liabilities	-0.27	0.73	0.73		-0.57	0.76	-0.86	0.24	0.37	0.65	-0.22	-0.84	-0.85	-0.22	-0.39	-0.11	-0.57	-0.75	-0.69	0.21	0.66	0.98	0.27	0.74	-0.19	-0.51
Total Stockholder Equity	0.03	-0.97	-0.21	-0.57		-0.47	0.38	-0.03	-0.28	0.02	0.07	0.39	0.36	0.07	0.17	0.34	0.35	0.4	0.44	-0.61	-0.38	-0.56	-0.06	-0.3	-0.01	0.34
Net Tangible Assets	0.4	0.56	0.84	0.76	-0.47		-0.82	0.3	-0.31	0.31	0.46	-0.86	-0.8	0.46	0.28	-0.59	-0.88	-0.92	-0.95	0.68	0.98	0.63	0.82	0.97	0.49	-0.76
Property Plant And Equipment Net	0.09	-0.56	-0.83	-0.86	0.38	-0.82		-0.41	-0.13	-0.76	0.0	1.0	0.99	0.0	0.2	0.21	0.78	0.94	0.89	-0.26	-0.82	-0.79	-0.54	-0.89	-0.02	0.68
Current Deferred Revenue	-0.05	0.09	0.71	0.24	-0.03	0.3	-0.41		0.02	0.16	0.01	-0.46	-0.33	0.01	-0.04	-0.56	-0.68	-0.51	-0.4	0.0	0.42	0.16	0.2	0.42	0.0	0.24
Net Debt	-0.97	0.37	-0.11	0.37	-0.28	-0.31	-0.13	0.02		0.5	-0.98	-0.06	-0.15	-0.98	-0.99	0.6	0.34	0.15	0.28	-0.59	-0.39	0.52	-0.76	-0.28	-0.96	0.32
Accounts Payable	-0.56	0.2	0.45	0.65	0.02	0.31	-0.76	0.16	0.5		-0.47	-0.7	-0.8	-0.47	-0.61	0.44	-0.24	-0.53	-0.41	-0.38	0.29	0.68	0.06	0.46	-0.48	-0.4
Cash	0.99	-0.15	0.21	-0.22	0.07	0.46	0.0	0.01	-0.98	-0.47		-0.07	0.02	1.0	0.98	-0.7	-0.47	-0.29	-0.43	0.75	0.53	-0.38	0.83	0.41	1.0	-0.45
Non Current Assets Total	0.01	-0.56	-0.87	-0.84	0.39	-0.86	1.0	-0.46	-0.06	-0.7	-0.07		0.98	-0.07	0.13	0.3	0.83	0.97	0.92	-0.32	-0.86	-0.77	-0.6	-0.92	-0.09	0.67
Non Currrent Assets Other	0.11	-0.54	-0.78	-0.85	0.36	-0.8	0.99	-0.33	-0.15	-0.8	0.02	0.98		0.02	0.22	0.13	0.72	0.92	0.87	-0.23	-0.79	-0.8	-0.53	-0.87	0.0	0.72
Cash And Short Term Investments	0.99	-0.15	0.21	-0.22	0.07	0.46	0.0	0.01	-0.98	-0.47	1.0	-0.07	0.02		0.98	-0.7	-0.47	-0.29	-0.43	0.75	0.53	-0.38	0.83	0.4	1.0	-0.45
Net Receivables	0.99	-0.28	0.06	-0.39	0.17	0.28	0.2	-0.04	-0.99	-0.61	0.98	0.13	0.22	0.98		-0.66	-0.31	-0.1	-0.24	0.66	0.36	-0.54	0.71	0.22	0.97	-0.28
Common Stock Shares Outstanding	-0.7	-0.27	-0.56	-0.11	0.34	-0.59	0.21	-0.56	0.6	0.44	-0.7	0.3	0.13	-0.7	-0.66		0.77	0.51	0.57	-0.77	-0.66	0.05	-0.64	-0.53	-0.73	0.16
Short Term Investments	-0.4	-0.43	-0.91	-0.57	0.35	-0.88	0.78	-0.68	0.34	-0.24	-0.47	0.83	0.72	-0.47	-0.31	0.77		0.93	0.93	-0.59	-0.95	-0.42	-0.78	-0.91	-0.49	0.51
Non Current Liabilities Total	-0.21	-0.53	-0.89	-0.75	0.4	-0.92	0.94	-0.51	0.15	-0.53	-0.29	0.97	0.92	-0.29	-0.1	0.51	0.93		0.98	-0.5	-0.95	-0.63	-0.74	-0.96	-0.31	0.7
Capital Lease Obligations	-0.36	-0.54	-0.83	-0.69	0.44	-0.95	0.89	-0.4	0.28	-0.41	-0.43	0.92	0.87	-0.43	-0.24	0.57	0.93	0.98		-0.64	-0.97	-0.56	-0.82	-0.96	-0.46	0.78
Other Current Assets	0.76	0.53	0.3	0.21	-0.61	0.68	-0.26	0.0	-0.59	-0.38	0.75	-0.32	-0.23	0.75	0.66	-0.77	-0.59	-0.5	-0.64		0.67	0.08	0.71	0.53	0.79	-0.6
Other Stockholder Equity	0.46	0.47	0.87	0.66	-0.38	0.98	-0.82	0.42	-0.39	0.29	0.53	-0.86	-0.79	0.53	0.36	-0.66	-0.95	-0.95	-0.97	0.67		0.52	0.87	0.98	0.55	-0.72
Total Liab	-0.43	0.72	0.61	0.98	-0.56	0.63	-0.79	0.16	0.52	0.68	-0.38	-0.77	-0.8	-0.38	-0.54	0.05	-0.42	-0.63	-0.56	0.08	0.52		0.1	0.62	-0.35	-0.43
Net Invested Capital	0.77	0.1	0.62	0.27	-0.06	0.82	-0.54	0.2	-0.76	0.06	0.83	-0.6	-0.53	0.83	0.71	-0.64	-0.78	-0.74	-0.82	0.71	0.87	0.1		0.82	0.84	-0.75
Property Plant And Equipment Gross	0.33	0.43	0.91	0.74	-0.3	0.97	-0.89	0.42	-0.28	0.46	0.41	-0.92	-0.87	0.4	0.22	-0.53	-0.91	-0.96	-0.96	0.53	0.98	0.62	0.82		0.42	-0.73
Total Current Assets	0.99	-0.08	0.21	-0.19	-0.01	0.49	-0.02	0.0	-0.96	-0.48	1.0	-0.09	0.0	1.0	0.97	-0.73	-0.49	-0.31	-0.46	0.79	0.55	-0.35	0.84	0.42		-0.47
Capital Stock	-0.4	-0.43	-0.38	-0.51	0.34	-0.76	0.68	0.24	0.32	-0.4	-0.45	0.67	0.72	-0.45	-0.28	0.16	0.51	0.7	0.78	-0.6	-0.72	-0.43	-0.75	-0.73	-0.47

Click cells to compare fundamentals

Cingulate Account Relationship Matchups

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:

How To Invest In Cingulate

Details

Is Cingulate Stock a good investment?

Details

What is Cingulate's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(43.22)

Return On Assets

(1.04)

Return On Equity

(2.74)

The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cingulate Total Liab vs Short Term Debt Analysis

Total Liab vs Short Term Debt

Total Liab vs Short Term Debt Correlation Analysis

Correlation Coefficient

Total Liab

Short Term Debt

Cingulate fundamental ratios Correlations

Cingulate Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets

Net Receivables	- 0.99	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Other Stockholder Equity	- 0.97	Capital Lease Obligations
Total Stockholder Equity	- 0.97	Short Long Term Debt Total
Net Debt	- 0.97	Total Assets